Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Australasian College of Cannabinoid Medicine (ACCM) is a professional organization dedicated to the education and training of healthcare professionals in the field of medicinal cannabis. It provides evidence-based clinical resources, certification programs, and research updates to doctors, pharmacists, and nurses across the Australasian region. The college aims to standardize the clinical application of cannabinoid therapies and improve patient outcomes through rigorous academic standards. ACCM also facilitates collaboration between researchers and clinicians to advance the understanding of the endocannabinoid system. By offering accredited courses, the institution ensures that practitioners are well-equipped to navigate the complex regulatory and therapeutic landscape of cannabis-based medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Australasian College of Cannabinoid.